Uber Analysts Increase Their Forecasts After Q4 Results

Uber Technologies, Inc (NYSE: UBER) reported better-than-expected sales for its fourth quarter on Wednesday.

Uber Technologies, Inc (NYSE:UBER) reported better-than-expected sales for its fourth quarter on Wednesday.

The company posted fourth-quarter FY23 revenue growth of 15% year-on-year to $9.94 billion, beating the consensus of $9.76 billion. Uber’s GAAP EPS of 29 cents beat the consensus of 17 cents, according to data from Benzinga Pro.

Revenue from Mobility grew to $5.54 billion, up 34% year-over-year, Delivery was $3.12 billion, up 6%, and Freight at $1.28 billion, which fell 17% year-over-year.

Gross Bookings grew 22% year-over-year to $37.58 billion, with Mobility Gross Bookings of $19.29 billion, up 29% year-over-year, Delivery Gross Bookings of $17.01 billion, up 19%, and Freight Gross Bookings of $1.28 billion, which fell 17% year-over-year.

Uber expects first-quarter gross bookings of $37.0 billion to $38.5 billion and an adjusted EBITDA of $1.26 billion to $1.34 billion. The first-quarter consensus for revenue and EPS are $10.02 billion and $0.20.

Uber shares gained 2% to close at $645.41 on Wednesday.

These analysts made changes to their price targets on Uber after the company reported quarterly results.

  • Needham raised the price target on Uber from $71 to $90. Needham analyst Bernie McTernan maintained a Buy rating.
  • JP Morgan boosted the price target on Uber from $76 to $84. JP Morgan analyst Doug Anmuth maintained an Overweight rating.
  • Roth MKM raised the price target on Uber from $72 to $79. Roth MKM analyst Rohit Kulkarni maintained a Buy rating.

 

Read This Next: ConocoPhillips, Disney And 3 Stocks To Watch Heading Into Thursday

Total
0
Shares
Related Posts
Read More

Here’s How To Enhance Marijuana Therapies: KindlyMD And Curaleaf Collab Provide More Resources And Information To Utah Patients

Healthcare data company KindlyMD, Inc. (NASDAQ: KDLY) has teamed up with the U.S. cannabis giant Curaleaf Holdings, Inc. (TSX: CURA)(OTCQX: CURLF) to provide educational resources and information with a community perspective on holistic pain management and treatment. KindlyMD said its providers will debut the KindlyMD Complete Care program, under which patients in Utah County and its surrounding areas would have the option to more easily access the medical cannabis care options offered by Curaleaf pharmacists.Tim Pickett, PA-C, founder and CEO at KindlyMD, said the goal of the new collaboration with CUraleaf is addressing the issue of the nation's opioid crisis and "negative impacts of addiction and overdose."

CURLF